Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeoMed IV Extension is a healthcare-focused investment vehicle associated with NeoMed Management, a Jersey-headquartered investment firm specializing in life science and medical technology investing. Available public evidence indicates that NeoMed IV Extension functions as a fund entity rather than an operating biotech, pharma, or healthcare products company. It appears to have been used as a shareholder and investment holding vehicle in portfolio companies such as Sequana Medical, and public references group it with other NeoMed funds including NeoMed Innovation V. As such, it does not appear to run its own therapeutic pipeline, drug development programs, or commercial healthcare products business. For biotech analyst purposes, the relevant takeaway is that NeoMed IV Extension is best classified as a healthcare venture investment entity tied to the broader NeoMed platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeoMed IV Extension.